Company Quick10K Filing
Boston Therapeutics
10-K 2020-12-31 Filed 2021-04-23
10-Q 2020-09-30 Filed 2020-12-28
10-Q 2020-06-30 Filed 2020-12-17
10-Q 2020-03-31 Filed 2020-11-30
10-K 2019-12-31 Filed 2020-06-08
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-14
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-04
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-18
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-01
10-Q 2010-09-30 Filed 2010-11-23
8-K 2020-05-15
8-K 2020-04-14
8-K 2020-01-10
8-K 2019-12-12
8-K 2019-12-02
8-K 2019-09-24
8-K 2018-11-30
8-K 2018-06-26
8-K 2018-06-12
8-K 2018-06-01
8-K 2018-02-12

Boston Therapeutics Financials

BTHE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
ALTIMAR ACQUISITION CORP. (ATAC-WT)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
AppHarvest, Inc. (APPHW)
AMERICAN CRYOSTEM Corp (CRYO)
Ameren Illinois Co (AILNP)
BorrowMoney.com, Inc. (BWMY)
CAT9 Group Inc. (CATN)
CBL & ASSOCIATES PROPERTIES INC (CBLEQ)
Cardiff Lexington Corp (CDIX)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
Alteryx (AYX) 7,562,700 90% 2,848.5 1% 1,239,309 852,574 350,610 316,953 12,996 2,429 6,918,891
1st Financial Services Corp (FFIS)
Finance of America Companies Inc. (FOA-WT)
Uluru (ULU) 20% 1.4 -31% 7,081 2,744 567 115 -2,203 -1,327 -1,813
AUGUSTA GOLD CORP. (AUGG)
Diversicare Healthcare Services (DVCR) 23,563 20% -21.4 -7% 449,140 482,968 388,353 76,008 -32,401 -3,872 82,790
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash33622626418169552385133,8643,3872,5121,5095691572202085841412192368739013229713720536311128119
Accounts Receivable81721121710043094031358511111110010
Inventory1224252524172516519011198173178198180127186110104103100555554423937321876
PP&E47799101518181714131198643243343332211
Assets1,2611,1509431,3171,0641,4351,3021,0605,1344,5353,4702,5661,7041,1631,2351,1261,0138788531,1711,6971,4051,0991,0471,1879043,4814,0984,2931,439930821743
Accounts Payable2173423213363522943563641151717296287411519659859575554523287319350297271299527481524510551595592
Long-Term Debt4974971,6021,7521,75236559379300
Liabilities6167257027688087398118346401,1906127929601,0881,4992,1371,6951,4091,4011,6976,4974,5244,9134,6655,6434,7875,9206,5775,8445,5855,9926,1516,362
Stockholders' Equity6454252415492566964902264,4943,3452,8571,77474375-264-1,011-682-531-548-526-4,801-3,119-3,815-3,618-4,456-3,884-3,577-3,616-2,688-4,146-5,061-5,329-5,619
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11192131923232188044211211351395412161259454159138454
Cost of Revenue3128229164829119104552282173267509216917529618
Gross Profit-2-0-9-2-73-25-699-23-11-139-419-28-45-87-48-66-4-1-13
R&D94675268112332922152342269530519232205974742220162642481896438540488383387
SG&A2482151922065745436097821,0571,9281,2781,014674520549386371301233166495292249203264351680726316245227257
Tax000000003011500-140-440000000000
Net Income-349-286-257-191-366-578-667-519-1,117-2,298-1,566-1,211-1,160-762-676-686-534-593-419-368-4,6201,669-7084,022-972-16-2,743-132765-952-282-303
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-110-200-166-245-242-415-372-1,036-516-1,121-1,001-939-412-369-12-246-667-402-169-442-236-294-453-255-211-269-31-54-386-404
Cash Investing00-4-3-20-2-6-4-2000000000-30-1400000
Cash Financing00562062525004,889462500004320976504021501,34401959627510030650389402